Illumina (ILMN) Tops Q2 EPS by 18c; offers guidance

Illumina (NASDAQ: ILMN) reported Q2 EPS of $1.19, $0.18 better than the analyst estimate of $1.01. Revenue for the quarter came in at $1.06 billion versus the consensus estimate of $1.05 billion.

GUIDANCE:

Illumina sees FY2025 EPS of $4.45-$4.55, versus the consensus of $4.24.

For earnings history and earnings-related data on Illumina (ILMN) click here.

You May Also Be Interested In

• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• CIGNA (CI) PT Raised to $381 at Bernstein SocGen Group
• Voya Financial estimates Q2 alternative investment pre-tax loss of $9M-$19M